114 related articles for article (PubMed ID: 21388809)
1. Discovery of benzothiazole-based adenosine A2B receptor antagonists with improved A2A selectivity.
Firooznia F; Cheung AW; Brinkman J; Grimsby J; Gubler ML; Hamid R; Marcopulos N; Ramsey G; Tan J; Wen Y; Sarabu R
Bioorg Med Chem Lett; 2011 Apr; 21(7):1933-6. PubMed ID: 21388809
[TBL] [Abstract][Full Text] [Related]
2. 4-Substituted-7-N-alkyl-N-acetyl 2-aminobenzothiazole amides: drug-like and non-xanthine based A2B adenosine receptor antagonists.
Cheung AW; Brinkman J; Firooznia F; Flohr A; Grimsby J; Gubler ML; Guertin K; Hamid R; Marcopulos N; Norcross RD; Qi L; Ramsey G; Tan J; Wen Y; Sarabu R
Bioorg Med Chem Lett; 2010 Jul; 20(14):4140-6. PubMed ID: 20541935
[TBL] [Abstract][Full Text] [Related]
3. Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonists.
Baraldi PG; Baraldi S; Saponaro G; Preti D; Romagnoli R; Piccagli L; Cavalli A; Recanatini M; Moorman AR; Zaid AN; Varani K; Borea PA; Tabrizi MA
J Med Chem; 2012 Jan; 55(2):797-811. PubMed ID: 22148859
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel quinolinone adenosine A2B antagonists.
McGuinness BF; Ho KK; Stauffer TM; Rokosz LL; Mannava N; Kultgen SG; Saionz K; Klon A; Chen W; Desai H; Rogers WL; Webb M; Yin J; Jiang Y; Li T; Yan H; Jing K; Zhang S; Majumdar KK; Srivastava V; Saha S
Bioorg Med Chem Lett; 2010 Dec; 20(24):7414-20. PubMed ID: 21055932
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
[TBL] [Abstract][Full Text] [Related]
7. 1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor.
Stefanachi A; Brea JM; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Vidal B; Carotti A
Bioorg Med Chem; 2008 Mar; 16(6):2852-69. PubMed ID: 18226909
[TBL] [Abstract][Full Text] [Related]
8. 3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A₂B adenosine receptor antagonists.
Taliani S; Pugliesi I; Barresi E; Simorini F; Salerno S; La Motta C; Marini AM; Cosimelli B; Cosconati S; Di Maro S; Marinelli L; Daniele S; Trincavelli ML; Greco G; Novellino E; Martini C; Da Settimo F
J Med Chem; 2012 Feb; 55(4):1490-9. PubMed ID: 22257095
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes.
El Maatougui A; Azuaje J; González-Gómez M; Miguez G; Crespo A; Carbajales C; Escalante L; García-Mera X; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2016 Mar; 59(5):1967-83. PubMed ID: 26824742
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of Tozadenant analogues as adenosine A
Renk DR; Skraban M; Bier D; Schulze A; Wabbals E; Wedekind F; Neumaier F; Neumaier B; Holschbach M
Eur J Med Chem; 2021 Mar; 214():113214. PubMed ID: 33548636
[TBL] [Abstract][Full Text] [Related]
11. Replacement of amide with bioisosteres led to a new series of potent adenosine A2A receptor antagonists.
Yang Z; Li X; Ma H; Zheng J; Zhen X; Zhang X
Bioorg Med Chem Lett; 2014 Jan; 24(1):152-5. PubMed ID: 24332624
[TBL] [Abstract][Full Text] [Related]
12. Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A(2B) adenosine receptor antagonists.
Eastwood P; Gonzalez J; Paredes S; Nueda A; Domenech T; Alberti J; Vidal B
Bioorg Med Chem Lett; 2010 Mar; 20(5):1697-700. PubMed ID: 20137946
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A
Basu S; Barawkar DA; Thorat S; Shejul YD; Patel M; Naykodi M; Jain V; Salve Y; Prasad V; Chaudhary S; Ghosh I; Bhat G; Quraishi A; Patil H; Ansari S; Menon S; Unadkat V; Thakare R; Seervi MS; Meru AV; De S; Bhamidipati RK; Rouduri SR; Palle VP; Chug A; Mookhtiar KA
J Med Chem; 2017 Jan; 60(2):681-694. PubMed ID: 28055204
[TBL] [Abstract][Full Text] [Related]
14. Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists.
Kalla RV; Elzein E; Perry T; Li X; Palle V; Varkhedkar V; Gimbel A; Maa T; Zeng D; Zablocki J
J Med Chem; 2006 Jun; 49(12):3682-92. PubMed ID: 16759111
[TBL] [Abstract][Full Text] [Related]
15. A
Basu S; Barawkar DA; Ramdas V; Waman Y; Patel M; Panmand A; Kumar S; Thorat S; Bonagiri R; Jadhav D; Mukhopadhyay P; Prasad V; Reddy BS; Goswami A; Chaturvedi S; Menon S; Quraishi A; Ghosh I; Dusange S; Paliwal S; Kulkarni A; Karande V; Thakre R; Bedse G; Rouduri S; Gundu J; Palle VP; Chugh A; Mookhtiar KA
Eur J Med Chem; 2017 Feb; 127():986-996. PubMed ID: 27842891
[TBL] [Abstract][Full Text] [Related]
16. Benzothiazole-based N-(phenylsulfonyl)amides as a novel family of PPARα antagonists.
Ammazzalorso A; Giancristofaro A; D'Angelo A; Filippis BD; Fantacuzzi M; Giampietro L; Maccallini C; Amoroso R
Bioorg Med Chem Lett; 2011 Aug; 21(16):4869-72. PubMed ID: 21742490
[TBL] [Abstract][Full Text] [Related]
17. N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 inhibitors. Part 1.
Haffner CD; Thomson SA; Guo Y; Schaller LT; Boggs S; Dickerson S; Gobel J; Gillie D; Condreay JP
Bioorg Med Chem Lett; 2010 Dec; 20(23):6983-8. PubMed ID: 20971642
[TBL] [Abstract][Full Text] [Related]
18. Potent and selective adenosine A(2A) receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones.
Harris JM; Neustadt BR; Zhang H; Lachowicz J; Cohen-Williams M; Varty G; Hao J; Stamford AW
Bioorg Med Chem Lett; 2011 Apr; 21(8):2497-501. PubMed ID: 21398125
[TBL] [Abstract][Full Text] [Related]
19. 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists.
Tabrizi MA; Baraldi PG; Preti D; Romagnoli R; Saponaro G; Baraldi S; Moorman AR; Zaid AN; Varani K; Borea PA
Bioorg Med Chem; 2008 Mar; 16(5):2419-30. PubMed ID: 18077171
[TBL] [Abstract][Full Text] [Related]
20. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
